Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

Market Cap	6.69B -8.6%
Revenue (ttm)	3.25B -5.0%
Net Income	299.79M -11.8%
EPS	0.53 -8.7%
Shares Out	566.16M
PE Ratio	22.29
Forward PE	19.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,886,701
Open	12.01
Previous Close	12.02
Day's Range	11.80 - 12.03
52-Week Range	11.80 - 20.20
Beta	0.45
Analysts	Strong Buy
Price Target	17.31 (+46.45%)
Earnings Date	Aug 28, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1975
• Employees: 5,379
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600557

Financial Performance

In 2025, SHA:600557's revenue was 3.29 billion, a decrease of -15.52% compared to the previous year's 3.90 billion. Earnings were 303.93 million, a decrease of -22.44%.